Lv1
30 积分 2024-07-10 加入
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy
2个月前
已完结
BAFF- and APRIL-targeted therapy in systemic autoimmune diseases
2个月前
已完结
New ELISA for B Cell–Activating Factor
2个月前
已完结
Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features
3个月前
已完结
The Role of Glomerular and Serum Expression of Lymphocyte Activating Factors BAFF and APRIL in Patient with Membranous and IgA Nephropathies
5个月前
已完结
Targeting APRIL in the treatment of glomerular diseases
5个月前
已完结
Profile of BAFF and its receptors’ expression in lupus nephritis is associated with pathological classes
5个月前
已完结
Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft
6个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
6个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
6个月前
已完结
皖公网安备34019202002308
